QT
AVXL icon

Quantbot Technologies’s Anavex Life Sciences AVXL Stock Holding History

Quantbot Technologies’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,730
Closed -$5.31K – 1927
2026
Q1 		$5.31K Buy
+1,730
New +$7.49K ﹤0.01% 1575
2024
Q2 		– Sell
-12,000
Closed -$61.1K – 1429
2024
Q1 		$61.1K Buy
+12,000
New +$67.5K ﹤0.01% 1302
2023
Q1 		– Sell
-2,800
Closed -$25.9K – 1539
2022
Q4 		$25.9K Sell
2,800
-18,000
-87% -$192K ﹤0.01% 1410
2022
Q3 		$214K Buy
20,800
+14,402
+225% +$152K 0.02% 858
2022
Q2 		$64K Buy
+6,398
New +$60.6K 0.01% 1245
2022
Q1 		– Sell
-536
Closed -$9K – 1631
2021
Q4 		$9K Sell
536
-5,700
-91% -$108K ﹤0.01% 1318
2021
Q3 		$111K Buy
6,236
+4,736
+316% +$94.3K 0.01% 938
2021
Q2 		$34K Buy
+1,500
New +$22.2K ﹤0.01% 1133

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantbot Technologies's AVXL Position: Q2 2026 in Review

Quantbot Technologies sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 1,730 shares — an estimated $5.31K sold.

Quantbot Technologies first reported a position in AVXL in Q2 2021 and held it in 8 quarters. The position peaked at $214K in Q3 2022. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Quantbot Technologies reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 1,730 Anavex Life Sciences shares in Q2 2026, an estimated $5.31K.
  • Quantbot Technologies first reported a position in Anavex Life Sciences in Q2 2021 and held it in 8 quarters.
  • Quantbot Technologies's Anavex Life Sciences position peaked at $214K in Q3 2022.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.